Skip to main content

Table 2 Audit of clinical records

From: Clinical audit of multidisciplinary care at a medium-sized hospital in Spain

Relevant cancer conference

Cases

MDT discussion

Prospective presentation

Written documentation

Explicitly documented cTNM

Explicitly documented pTNM

Diagnostic delay

Therapeutic delay

General

496

320 (64.5%)

198 (40%)

259 (52%)

118 (23.8%)

266 (53.6%)

33

21

Gastrointestinal

147

124 (84.3%)

87 (59.1%)

116 (78.9%)

58 (39.4%)

89 (60.5%)

30

21

Breast

46

43 (93%)

38 (82.6%)

43 (93%)

9 (19.5%)

35 (76%)

28

28

Lung

68

36 (52.9%)

15 (21.7%)

10 (14.5%)

11 (16.1%)

24 (35.3%)

13

10

Hematology

33

14 (42%)

7 (21%)

8 (24%)

na

na

na

na

Urology

81

46 (56.7%)

15 (18.5%)

28 (34.5%)

11 (13.5%)

52 (64.2%)

46

33

Gynecology

23

19 (82.6%)

10 (43.5%)

16 (69.6%)

5 (21.7%)

16 (69.6%)

34

31

H and N

28

16 (57%)

8 (28.6%)

8 (28.6%)

11 (39.3%)

19 (67.8%)

46

19

Sarcomas

5

5 (100%)

2 (40%)

1 (20%)

1 (20%)

3 (60%)

41

15

Melanoma

16

14 (87.5%)

2 (40%)

11 (68.7%)

3 (18.7%)

11 (68.7%)

13

56

Other: Unknown origin, Thyroid, Brain, Peritoneum

41

4 (9.7%)

2 (4.9%)

1 (2.4%)

1 (2.4%)

7 (17.1%)

50

23

  1. H and N, head and neck; na, not available due to the specific characteristics of hematological cancers. MDT (multidisciplinary team); cTNM (clinical staging); pTNM (pathological staging).